Institution statistics

THE NETHERLANDS CANCER INSTITUTE/ANTONI VAN LEEUWENHOEK HOSPITAL - Netherlands 

Ranking results:

Past rankings:
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 15
As coordinator: 0
As participant: 12
Sole participant: 3
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2006 0 12.000.000 521.739 1
2005 150.977 13.399.341 784.237 1 2
2004 0 13.000.000 431.818 2
2002 0 16.446.253 874.421 4
2001 140.400 2.196.143 414.918 1 1
2000 140.800 1.646.661 523.096 1 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE6
KAROLINSKA INSTITUTE6
EUROPEAN MOLECULAR BIOLOGY LABORATORY4
INSTITUT PASTEUR4
MEDICAL RESEARCH COUNCIL3
AGENDIA BV2
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING2
DEUTSCHES KREBSFORSCHUNGSZENTRUM2
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
LUDWIG INSTITUT FUER KREBSFORSCHUNG2
LUDWIG INSTITUT FUER KREBSFORSCHUNG2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
UNIVERSITAET ZU KOELN2
UNIVERSITY OF DUNDEE2
UNIVERSITY OF YORK2
WEIZMANN INSTITUTE OF SCIENCE2
1ST MEDICAL FACULTYCHARLES UNIVERSITY AND GENERAL TEACHING HOSPITAL1
A PERSIDIS & SIA OE1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA1
AMYNON BIOTECH1
AREXIS AB1
AUSTRIAN ACADEMY OF SCIENCES1
BEREICH HUMANMEDIZIN DER GEORG AUGUST UNIVERSITAET GOETTINGEN1
BI TECHNOLOGY A/S BANK INVEST GROUP1
BIOMEDCODE HELLAS1
BIOVITRUM AB1
BREAST INTERNATIONAL GROUPAISBL1
BRUKER ANALYTISCHE MESSTECHNIK1
CANCER RESEARCH UK1
CENTRE HOSPITALIER DE LUXEMBOURG1
CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS1
CHALMERS TEKNISKA HOGSKOLA AB1
CHRISTIAN DE DUVE INSTITUTE OF CELLULAR PATHOLOGY1
CONSIGLIO NAZIONALE DELLE RICERCHE ISTITUTO DI BIOLOGIA CELLULARE1
CONSORZIO INTERUNIVERSITARIO BIOTECNOLOGIE1
CONSORZIO INTERUNIVERSITARIO RISONANZE MAGNETICHE DI METALLOPROTEINE PARAMAGNETICHE1
COPENHAGEN UNIVERSITY HOSPITAL1
COUNCIL FOR THE CENTRAL LABORATORY OF THE RESEARCH COUNCILS1
CYTOMICS SYSTEMS1
CYTOS BIOTECHNOLOGY1
DANISH CANCER SOCIETY1
DEPARTMENT OF ONCOLOGY FINSEN CENTRE RIGSHOSPITALET1
DEPARTMENT OF SURGERY UNIVERSITY OF VIENNA1
DEUTSCHES RHEUMAFORSCHUNGSZENTRUM BERLIN1
DRUG DISCOVERY FACTORY BV1
ENZO LIFE SCIENCES LIMITED1
EUROPA DONNA THE EUROPEAN BREAST CANCER COALITION1
EUROPEAN CANCER ORGANISATION1
EUROPEAN ORGANISATION FOR THE RESEARCH AND TREATMENT OF CANCER1
EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER1
EUROPEAN SYNCHROTRON RADIATION FACILITY1
FLANDERS INTERUNIVERSITY INSTITUTE FOR BIOTECHNOLOGY VZW1
FONDAZIONE PIEMONTESE PER LA RICERCA SUL CANCRO ONLUS1
FORSCHUNGSINSTITUT FUER MOLEKULARE PATHOLOGIE GESMBH1
FUNDACIO INSTITUT PER LA RECERCA VALL D'HEBRON1
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III1
GENETIX GROUP PLC1
GENOPOLIS FUNCTIONAL GENOMICS CONSORTIUM1
GEORG AUGUST UNIVERSITAET GOETTINGEN1
GERMAN CANCER SOCIETY1
GLOBAL PHASING LIMITED1
GROUPEMENT D'INTERET ECONOMIQUE CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE1
GRUPO ESPANOL DE ESTUDIO Y TRATAMIENTO TUMOURES SOLIDES1
GRUPO ONCOLOGICO COOPERATIVO CHILENO DE INVESTIGACION1
GRUPPO ONCOLOGICO ITALIANO DI RICERCA CLINICA1
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT1
HELMHOLTZ ZENTRUM FUER INFEKTIONSFORSCHUNG1
HUMANITAS MIRASOLE1
IMMUNE DISEASE INSTITUTE INC1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INNATE PHARMA S A1
INSTITUT CURIE1
INSTITUT GUSTAVE ROUSSY1
INSTITUT JULES BORDET1
INSTITUTE FOR ANIMAL HEALTH1
INSTITUTE FOR RESEARCH IN BIOMEDICINE1
INSTITUTE OF ONCOLOGY LJUBLJANA1
INSTITUTE OF ONCOLOGY OF SOUTHERN SWITZERLAND1
INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO1
INSTITUTO DE TECNOLOGIA QUIMICA E BIOLOGICA UNIVERSIDADE NOVA DE LISBOA1
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI1
ISTITUTO EUROPEO DI ONCOLOGIA1
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT1
KING'S COLLEGE LONDON1
KLINIKUM DER JOHANN WOLFGANG GOETHE UNIVERSITAET FRAUENKLINIK1
KLINIKUM NUERNBERG1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
LEOPOLD FRANZENS UNIVERSITAET INNSBRUCK1
LUDWIG INSTITUTE FOR CANCER RESEARCH UPPSALA BRANCH1
LUNDS UNIVERSITET1
MALARSJUKHUSET1
MARMARA UNIVERSITY MEDICAL SCHOOL HOSPITAL1
MARTIN LUTHER UNIVERSITAET HALLE WITTENBERG1
MATER MISERICORDIAE HOSPITAL1
MAX DELBRUCK CENTER FOR MOLECULAR MEDICINE1
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN1
MAX PLANCK SOCIETY FOR THE ADVANCEMENT OF SCIENCE1
MAXDELBRUECKCENTRUM FUER MOLEKULARE MEDIZIN1
Constancy:

Total number of partners:187

Partner loyalty:
Frequent Partner: (> 2 projects): 23
Rare Partner: 164

Frequent / Rare Partner Ratio: 0.14

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES11
RTD HORIZONTAL TOPICS10
SOCIAL AND ECONOMIC CONCERNS8
AGRICULTURE AND MARINE RESOURC1
PROTECTING MAN AND HIS ENVIRON1

Project overview:

Start dateProjectacronymrolefundingpartners
2006-01-01Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation RUBICONparticipant12.000.00023
2005-03-01Molecular mechanisms of epithelial plasticity and its involvement in carcinoma progression EPIPLASTCARCINOMAparticipant2.399.3419
2005-01-01Integrated functional genomics in mutant mouse models as tools to investigate the complexity of human immunological disease MUGENparticipant11.000.00030
2005-01-01Identification and characterization of novel genes involved in DNA damage- response pathways in humans DNA DAMAGE - RNAIcoordinator150.9771
2004-06-01Translational and Functional Onco-Genomics: from cancer-oriented genomic screenings to new diagnostic tools and improved cancer treatment. TRANSFOGparticipant6.000.00022
2004-03-01Translating molecular knowledge into early breast cancer management: building on the BIG (Breast International Group) network for improved treatment tailoring - TRANS-BIG TRANS-BIGparticipant7.000.00044
2002-11-01Passage from intestine to brain: assessing the role of dendritic cells in capturing, expanding and disseminating prions IMMUNOTSEparticipant1.522.7588
2002-10-01Structural proteomics in Europe SPINEparticipant13.700.00025
2002-10-01Complementary and alternative medicine - assessment in the cancer field CAM-CANCERparticipant636.4117
2002-01-01Pooling of European data to hamonise transnational research in breast cancer ONCOPOOLparticipant587.08413
2001-10-01Molecular mechanisms of senescence and ageing (CELLAGE) CELLAGEparticipant2.196.1438
2001-09-01Structural characterisation of the human l1 retroposition machinery coordinator140.4001
2000-10-01Determination of macromolecular crystal structures: integrated, automated and user-friendly approaches AUTOSTRUCTparticipant749.6619
2000-02-01Functional analysis of the mammalian sir2 gene family coordinator140.8001
2000-02-01Development of anti-melanoma therapies: the animal model stage. INDUCIBLE MELANOMA Mparticipant897.0003
Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum